Open access
Sep 2026
Co-Delivery of Fluconazole and Riparin B Using Nanostructured Lipid Carriers: A Quality-by-Design Approach for Enhanced Antifungal Activity
Background/Objectives: The increasing incidence of invasive fungal infections and the emergence of antifungal resistance have limited the effectiveness of conventional therapies against Candida spp. This study aimed to develop and optimize nanostructured lipid carriers (NLCs) containing fluconazole (FLC) and Riparin B...
M. O. Do Nascimento, Leandro de Sousa Dias, Allan Kayk Sales Meneses et al.
· Pharmaceutics · 0 citations